Empower A Diverse Workforce
Our long-standing values of integrity, excellence and respect for people foster an environment where team members are encouraged to speak up, share ideas and be fully engaged in our work, while bringing their full authentic selves to work every day. By including everyone, we ensure that we can innovate, accelerate and deliver life-changing medicines that make a difference for people around the world.
We celebrate our differences and understand that a variety of perspectives is critical to continuous innovation. We take a rigorous, research-based approach to diversity and inclusion (D&I) to ensure that our business reflects the world around us. We were proud to be one of four companies to receive the prestigious global Catalyst Award in 2019, and to rank No. 3 in DiversityInc’s Top 50 Companies for Diversity in 2020.
We have seen significant improvement in representation for women globally and for Black Americans, Asians and Latinos in the United States.
Women are now 46% of global management, up from 38% at the beginning of 2017. Racial and ethnic minorities comprise 22% of U.S. management, up from 16% in early 2017.
A key factor in this progress is the aspirational goals we set in 2017. In 2021, we are expanding aspirational goals to cover additional career paths and levels and to include greater accountability for leaders. We also require, for example, diverse pools of candidates and diverse interview panels for every open role.
Lilly invests in employees’ growth by providing resources for career and leadership development. We want every individual at Lilly to reach their fullest potential, which is why we strive to offer the tools and resources to support them on their journey.
As Team Lilly develops and evolves, so, too, does the company. And our impact on society.
At this pivotal moment in American society, with communities galvanized to address racial justice, Lilly’s commitment to diversity, equity and inclusion inside our company is not enough. We are taking action to influence meaningful, lasting change.
Lilly and the Lilly Foundation’s Racial Justice Initiative is investing to create more jobs and economic opportunity while partnering to drive social change, such as:
Expanding diversity in Lilly’s clinical trials programs; joining forces with other major companies to hire, train and advance Black Americans into one million family-sustaining jobs, through a partnership with the OneTen coalition; doubling Lilly’s spend with diverse suppliers; and building or strengthening existing community and national partnerships to help drive social change.
Committing $30 million to Unseen Capital Health Fund LP, a newly formed venture fund created by Black Americans and other minority business leaders. The fund is intended to identify, fund and support diverse founders of early-stage healthcare companies and those building solutions for marginalized communities.
We don’t claim to have all the answers. We are investing and partnering with community-based local and national organizations and with business and financial partners to develop solutions to drive meaningful progress.
To solve some of the toughest challenges in medicine, we need the best people with the best, most creative ideas. We embrace our differences, and it’s driving business success.
David A. RicksChairman and CEO